3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Classical hematology
1
Conditions
Venous Thromboembolism
1
TP53 Y220C Mutation
1
Sarcoma, Synovial
1
Sarcoma, Alveolar Soft Part
1
Sarcoma
1
Pulmonary Embolism
1
Prostatic Neoplasms, Castration-Resistant
1
Peripheral Nervous System Diseases
1
Neoplasms
1
Liver Cirrhosis
1
Leiomyosarcoma
1
Healthy Participants
1
Healthy Adult Participants
1
Endometrial Neoplasms
1
Cardiotoxicity
1
Breast Neoplasms
1
Advanced Solid Malignancies
1
Interventions
apixaban
10
Rivaroxaban
5
Aspirin
4
Enoxaparin
3
abelacimab
2
MAA868
2
Heparin, Low-Molecular-Weight
2
Dalteparin
2
ribociclib
1
palbociclib
1
isoquercitrin
1
enoxaparin sodium
1
edoxaban
1
abemaciclib
1
Rosuvastatin Calcium
1
N(4)-oleylcytosine arabinoside
1
Educational Status
1
Dabigatran
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Venous Thromboembolism
×
Rosuvastatin Calcium
×
1 year
×
Clear all
NCT07303816
2026-06-01
STAT-CAT
Brigham and Women's Hospital
Phase 4
Not yet recruiting
4,000 enrolled